Blood Res.  2013 Jun;48(2):152-153. 10.5045/br.2013.48.2.152.

Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome

• Niscola P
• Tendas A
• Scaramucci L
• Giovannini M
• Fratoni S
• de Fabritiis P

• KMID: 2172917
• DOI: http://doi.org/10.5045/br.2013.48.2.152

Abstract

No abstract available.

MeSH Terms

Leukemia, Myelomonocytic, Chronic
Myelodysplastic Syndromes

Reference

1. Bursztyn B, Douer D, Ramot B. Chronic myelomonocytic leukemia following refractory anemia with sideroblasts: report of two cases. Eur J Haematol. 1987; 38:197–199. PMID: 3474153.

2. Hasegawa Y, Sakai N, Toyama M, Ninomiya H, Abe T. Chronic myelomonocytic leukemia transformed from refractory anemia with ring sideroblasts with a rare abnormal chromosome, inv (12). Rinsho Ketsueki. 1990; 31:75–79. PMID: 2179602.

3. D'Angelo G. Refractory anemia with ringed sideroblasts and chronic myelomonocytic leukemia: myelodysplastic/myeloproliferative disease. Lab Hematol. 2005; 11:171–173. PMID: 16174602.

4. Breccia M, Cannella L, Frustaci A, Stefanizzi C, D'Elia GM, Alimena G. Chronic myelomonocytic leukemia with antecedent refractory anemia with excess blasts: further evidence for the arbitrary nature of current classification systems. Leuk Lymphoma. 2008; 49:1292–1296. PMID: 18604717.

5. Singh ZN, Post GR, Kiwan E, Maddox AM. Cytopenia, dysplasia, and monocytosis: a precursor to chronic myelomonocytic leukemia or a distinct subgroup? Case reports and review of literature. Clin Lymphoma Myeloma Leuk. 2011; 11:293–297. PMID: 21658659.

6. Parikh SA, Tefferi A. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management. Am J Hematol. 2012; 87:610–619. PMID: 22615103.

7. Fianchi L, Criscuolo M, Breccia M, et al. High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study. Leuk Lymphoma. 2013; 54:658–661. PMID: 22873829.

8. Onida F, Kantarjian HM, Smith TL, et al. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. Blood. 2002; 99:840–849. PMID: 11806985.

9. Lyons RM, Cosgriff TM, Modi SS, et al. Hematologic response to three alternative dosing schedules of azacitidine in patients with myelodysplastic syndromes. J Clin Oncol. 2009; 27:1850–1856. PMID: 19255328.

10. Gelsi-Boyer V, Cervera N, Bertucci F, et al. Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts. Haematologica. 2013; 98:576–583. PMID: 23065512.